Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T20:35:23.595Z.
Calculation as of: 2026-10-06T20:35:23.595Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 026981202cadb8e73b6cbd63f18abfa8ffa74fea80ac6bbb32512047e0825b9f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$2.28B
EV/FCF Ratio
5.31x
TTM Avg
4.85x
3Y Avg
7.14x
5Y Avg
13.46x
Market Cap
$2.17B
EV/FCF Ratio
N/A
TTM Avg
7.18x
3Y Avg
10.07x
5Y Avg
14.95x
Market Cap
$2.30B
EV/FCF Ratio
35.51x
TTM Avg
106.68x
3Y Avg
106.68x
5Y Avg
106.68x
Market Cap
$2.13B
EV/FCF Ratio
N/A
TTM Avg
1592.69x
3Y Avg
1592.69x
5Y Avg
1592.69x
Market Cap
$2.34B
EV/FCF Ratio
40.22x
TTM Avg
26.99x
3Y Avg
39.76x
5Y Avg
80.04x
Market Cap
$2.35B
EV/FCF Ratio
N/A
TTM Avg
74.09x
3Y Avg
74.09x
5Y Avg
74.09x
Market Cap
$2.36B
EV/FCF Ratio
20.84x
TTM Avg
65.64x
3Y Avg
95.37x
5Y Avg
95.37x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.24B | N/A | N/A | N/A | N/A |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 5.31x | 4.85x | 7.14x | 13.46x |
| Pharvaris N.V. (PHVS)vs › | $2.17B | N/A | N/A | N/A | N/A |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | N/A | 7.18x | 10.07x | 14.95x |
| Liquidia Corporation (LQDA)vs › | $2.30B | 35.51x | 106.68x | 106.68x | 106.68x |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | N/A | 1592.69x | 1592.69x | 1592.69x |
| UFP Technologies, Inc. (UFPT)vs › | $2.34B | 40.22x | 26.99x | 39.76x | 80.04x |
| Nurix Therapeutics, Inc. (NRIX)vs › | $2.35B | N/A | 74.09x | 74.09x | 74.09x |
| ADMA Biologics, Inc. (ADMA)vs › | $2.36B | 20.84x | 65.64x | 95.37x | 95.37x |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 13.86x | 18.28x | 18.51x | 20.32x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
